Literature DB >> 10221943

Hepatotoxicity associated with zolpidem treatment.

D Karsenti1, P Blanc, Y Bacq, E H Metman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221943      PMCID: PMC27854          DOI: 10.1136/bmj.318.7192.1179

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

2.  [Subfulminant hepatitis caused by alpidem and treated by liver transplantation].

Authors:  P Ausset; P Malavialle; A Vallet; G Miremont; B Le Bail; F Dumas; J Saric; S Winnock
Journal:  Gastroenterol Clin Biol       Date:  1995-02

3.  [Hepatitis induced by alpidem (Ananxyl). Four cases, one of them fatal].

Authors:  V Baty; B Denis; C Goudot; V Bas; P Renkes; M A Bigard; P Boissel; P Gaucher
Journal:  Gastroenterol Clin Biol       Date:  1994

4.  Acute zolpidem poisoning--analysis of 344 cases.

Authors:  R Garnier; E Guerault; D Muzard; P Azoyan; A E Chaumet-Riffaud; M L Efthymiou
Journal:  J Toxicol Clin Toxicol       Date:  1994
  4 in total
  3 in total

Review 1.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 2.  New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.

Authors:  Mario Giovanni Terzano; Mariano Rossi; Vincenzo Palomba; Arianna Smerieri; Liborio Parrino
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 3.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.